A TP53 founder mutation, p.R337H, is associated with phyllodes breast tumors in Brazil

[1]  P. Hainaut,et al.  Contribution of TP53 p.R337H mutation to breast cancer prevalence in Brazil , 2012 .

[2]  S. Narod,et al.  The R337H mutation in TP53 and breast cancer in Brazil , 2012, Hereditary cancer in clinical practice.

[3]  J. A. Yunes,et al.  Association of the highly prevalent TP53 R337H mutation with pediatric choroid plexus carcinoma and osteosarcoma in Southeast Brazil , 2011, Cancer.

[4]  E. Lalli,et al.  Increased Incidence of Choroid Plexus Carcinoma Due to the Germline TP53 R337H Mutation in Southern Brazil , 2011, PloS one.

[5]  P. Ashton-Prolla,et al.  Abstract P3-06-02: Prevalence ofTP53p.R337H Mutation in Cases of Breast Phyllodes Tumours in Southern Brazil , 2010 .

[6]  M. Olivier,et al.  Detailed haplotype analysis at the TP53 locus in p.R337H mutation carriers in the population of Southern Brazil: evidence for a founder effect , 2010, Human mutation.

[7]  R. Montironi,et al.  Evidence for Transformation of Fibroadenoma of the Breast to Malignant Phyllodes Tumor , 2009, Applied immunohistochemistry & molecular morphology : AIMM.

[8]  D. Albertson,et al.  Genomic Profiling by Array Comparative Genomic Hybridization Reveals Novel DNA Copy Number Changes in Breast Phyllodes Tumours , 2008, Cellular oncology : the official journal of the International Society for Cellular Oncology.

[9]  S. Shurtleff,et al.  Association of the germline TP53 R337H mutation with breast cancer in southern Brazil , 2008, BMC Cancer.

[10]  G. Sadler,et al.  Malignant Phyllodes Tumors: A Review of 752 Cases , 2007, The American surgeon.

[11]  M. Olivier,et al.  The TP53 mutation, R337H, is associated with Li-Fraumeni and Li-Fraumeni-like syndromes in Brazilian families. , 2007, Cancer letters.

[12]  R. Walker,et al.  World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Breast and Female Genital Organs , 2005 .

[13]  M. Trková,et al.  A Li-Fraumeni syndrome family with retained heterozygosity for a germline TP53 mutation in two tumors. , 2003, Cancer genetics and cytogenetics.

[14]  S. Sahoo,et al.  Benign Phyllodes Tumor of the Male Breast , 2002, The breast journal.

[15]  E. Pinto,et al.  An inherited mutation outside the highly conserved DNA-binding domain of the p53 tumor suppressor protein in children and adults with sporadic adrenocortical tumors. , 2001, The Journal of clinical endocrinology and metabolism.

[16]  J. Varley,et al.  Relative frequency and morphology of cancers in carriers of germline TP53 mutations , 2001, Oncogene.

[17]  C. Stratakis,et al.  An inherited p53 mutation that contributes in a tissue-specific manner to pediatric adrenal cortical carcinoma , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[18]  L. Sobin,et al.  World Health Organization classification of tumors , 2000, Cancer.

[19]  A. Scarpa,et al.  Pathology and Genetics , 2010 .

[20]  J. Fraumeni,et al.  Multiple primary cancers in families with Li-Fraumeni syndrome. , 1998, Journal of the National Cancer Institute.

[21]  D. Evans,et al.  Germ-line mutations of TP53 in Li-Fraumeni families: an extended study of 39 families. , 1997, Cancer research.

[22]  S. Schraub,et al.  Two germ-line mutations affecting the same nucleotide at codon 257 of p53 gene, a rare site for mutations. , 1994, Oncogene.

[23]  J. Yokota,et al.  Germ-line p53 mutation is uncommon in patients with triple primary cancers. , 1993, Cancer letters.

[24]  L. Bernstein,et al.  The descriptive epidemiology of malignant cystosarcoma phyllodes tumors of the breast , 1993, Cancer.

[25]  D. Lane,et al.  p53, guardian of the genome , 1992, Nature.

[26]  F. Tavassoli,et al.  Fibroadenoma and cystosarcoma phyllodes of the male breast. , 1992, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[27]  L. Strong,et al.  Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. , 1990, Science.

[28]  J. Fraumeni,et al.  Soft-tissue sarcomas, breast cancer, and other neoplasms. A familial syndrome? , 1969, Annals of internal medicine.

[29]  P. Chu,et al.  Tumors of the breast and female genital organs , 2014 .

[30]  C. Mathers,et al.  GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer , 2013 .

[31]  P. Johnstone,et al.  National Surgical Patterns of Care for Primary Surgery and Axillary Staging of Phyllodes Tumors , 2009, The breast journal.

[32]  L. Forétova,et al.  A rare tumor and an ethical dilemma in a family with a germline TP53 mutation. , 2008, Cancer genetics and cytogenetics.

[33]  P. Hainaut.  Tumor-specific mutations in p53: The acid test , 2002, Nature Medicine.

[34]  L. Liberman,et al.  Benign and malignant phyllodes tumors: mammographic and sonographic findings. , 1996, Radiology.

[35]  A. D. Tos,et al.  Fibroepithelial tumor [1] , 1995 .

[36]  M. Vilain,et al.  [Phyllodes tumors]. , 1995, Archives d'anatomie et de cytologie pathologiques.

[37]  D. Lane,et al.  Cancer. p53, guardian of the genome. , 1992, Nature.